A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis? 2008

Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008676 Metanephrine Product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine. Metadrenaline
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
January 1982, The New England journal of medicine,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
July 1982, The New England journal of medicine,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
September 1985, Orvosi hetilap,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
September 1981, The New England journal of medicine,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
January 1985, Cardiology,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
September 1988, Klinische Wochenschrift,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
January 1986, Acta medica Scandinavica. Supplementum,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
June 1988, The American journal of medicine,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
October 1986, World journal of surgery,
Michelangelo Sartori, and Alessandro Cosenzi, and Elena Bernobich, and Lorenzo A Calo, and Giuseppe Bellini, and Andrea Semplicini
November 2022, Clinical endocrinology,
Copied contents to your clipboard!